Reaction to White House Blog Post on H.R. 3
Council of Economic Advisers analysis puts politics over patients.
Council of Economic Advisers analysis puts politics over patients.
Making sure that I am in a position to be able to get my medication is something I will stress about for the rest of my life.
Read what independent experts are saying about H.R. 3, a bill to lower drug prices.
High prices not only pose a challenge to patient access, but they also raise a fundamental question: Are we creating these therapies the wrong way?
Three drug manufacturers control the global insulin market and have raised prices on American patients by nearly 300% in the last ten years.
On World Diabetes Day, Patients Demand Action To Address The Insulin Pricing Crisis.
I’ve been forced to use expired insulin because there’s no way I can afford to pay $214 again.
More than 13% of American adults -- or about 34 million people -- report knowing of at least one friend or family member in the past five years who died after not receiving needed medical treatment because they were unable to pay for it.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.